| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/03/2005 | EP1438307B1 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 08/03/2005 | EP1330455B1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 08/03/2005 | EP1227806B1 Pharmaceutical formulation containing tolterodine and its use |
| 08/03/2005 | EP1140106B1 Treatment of diseases involving cyst formation |
| 08/03/2005 | EP0851925B1 Human growth hormone variants |
| 08/03/2005 | CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/03/2005 | CN1649876A 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 08/03/2005 | CN1649870A 7-aryl-3, 9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases |
| 08/03/2005 | CN1649867A Novel 1, 2, 3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same |
| 08/03/2005 | CN1649863A Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity |
| 08/03/2005 | CN1649857A Hydroxamic acid derivatives |
| 08/03/2005 | CN1649853A Thiazolidinones compound, its preparing method and use as medicine |
| 08/03/2005 | CN1649849A Tachykinin receptor antagonists |
| 08/03/2005 | CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF) |
| 08/03/2005 | CN1649843A Novel chalcone derivatives and uses thereof |
| 08/03/2005 | CN1649841A Piperidine derivative compound and drug containing the same compound as active ingredient |
| 08/03/2005 | CN1649624A Use of TNF alpha antibodies and another drug |
| 08/03/2005 | CN1649595A Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 08/03/2005 | CN1649593A Use of 2-alkoxyphenyl-substituted imidazotriazinones |
| 08/03/2005 | CN1649582A Amino-methyl substituted tetracycline compounds |
| 08/03/2005 | CN1649581A Substituted 3-amino-thieno(2, 3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 08/03/2005 | CN1649577A Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 08/03/2005 | CN1649574A Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies |
| 08/03/2005 | CN1648134A Dog intravenous injection albumin, its preparing method and dog intravenous injection albumin preparation |
| 08/03/2005 | CN1647795A Fatty acyl acetaldehyde transfusion preparation and its preparing method |
| 08/03/2005 | CN1647794A Fatty acyl acetaldehyde powder projection and its preparing method |
| 08/03/2005 | CN1213071C Sulfated polyguluronic Acid Ester and its preparation method and uses |
| 08/03/2005 | CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 08/03/2005 | CN1212859C Acute cystourethritis treating medicine |
| 08/02/2005 | US6924314 Compounds for the treatment of metabolic disorders |
| 08/02/2005 | US6924305 Diazocine derivatives and their use as tryptase inhibitors |
| 08/02/2005 | US6924297 Naphathalene derivatives which bind to the EP4 receptor |
| 08/02/2005 | US6924281 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 08/02/2005 | US6924280 Dipeptide derivatives |
| 08/02/2005 | US6924277 Central nervous system disorders; antidepressants; bipolar disorders; rhematic diseases |
| 08/02/2005 | US6924276 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
| 08/02/2005 | US6924266 NTP-peptides and method for removal of tumors |
| 08/02/2005 | US6924110 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 08/02/2005 | US6923988 Solid carrier includes a hydrophililc surfactant and a drug |
| 08/02/2005 | CA2321639C Bicyclo[2.2.1]heptanes and related compounds |
| 08/02/2005 | CA2132537C Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 07/28/2005 | WO2005068467A1 Novel fused-ring compound |
| 07/28/2005 | WO2004093828A3 Reverse-turn mimetics and method relating thereto |
| 07/28/2005 | WO2003072035A8 Compositions and methods for the treatment of immune related diseases |
| 07/28/2005 | US20050166274 Compositions and methods for the diagnosis and treatment of tumor |
| 07/28/2005 | US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase |
| 07/28/2005 | US20050165103 for enhancing the endogenous production of interleukin-10 (IL-10) and suppressing the production of interleukin-2 in mammalian cells or tissues; inhibiting the proliferation of stimulated peripheral mononuclear cells |
| 07/28/2005 | US20050165087 Nf-kb inhibitors |
| 07/28/2005 | US20050165086 Aminothiophene inhibitors of NF- kappa B inhibitors for treatment of diseases such as cancer or aids |
| 07/28/2005 | US20050165064 Novel thiol derivative, process for producing the same and use thereof |
| 07/28/2005 | US20050165039 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 07/28/2005 | US20050165023 Imidazo-triazine derivatives as ligands for gaba receptors |
| 07/28/2005 | US20050165022 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050165011 6-[5-(6-methyl-pyridin-2-yl)-1H-[1,2,3]triazol-4-yl]-4H-benzo[1,4]oxazin-3-one, used as inhibitors of the transforming growth factor beta-signalling pathways, in particular, the phosphorylation of smad gene and proteins or activin-like kinase receptors; prophylaxis of kidney fibrosis |
| 07/28/2005 | US20050164926 Novel recombinant anticoagulant proteins |
| 07/28/2005 | US20050164305 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 07/28/2005 | US20050164233 Compositions, kits and methods for identification and modulation of type I diabetes |
| 07/28/2005 | DE10043321B4 Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung Use of a transdermal therapeutic system for the treatment of Parkinson's disease, for the treatment and prevention of premenstrual syndrome and Lactationshemmung |
| 07/28/2005 | CA2553329A1 New fused polycyclic compounds |
| 07/28/2005 | CA2552965A1 Carboxamide derivative and use thereof |
| 07/27/2005 | EP1557430A1 Antibody and utilization of the same |
| 07/27/2005 | EP1557411A1 N-phenyl-(2r,5s)dimethylpiperadine derivative |
| 07/27/2005 | EP1557409A1 5HT2C receptor modulators |
| 07/27/2005 | EP1557175A1 Remedy for bone metabolic diseases |
| 07/27/2005 | EP1557172A1 Method and composition for regulating the activity of regulatory t cells |
| 07/27/2005 | EP1556705A2 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 14 (gpr14) |
| 07/27/2005 | EP1556488A2 Hf-chondroosteomodulin, production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 07/27/2005 | EP1556401A2 22 human secreted proteins |
| 07/27/2005 | EP1556376A1 Large conductance calcium-activated k channel opener |
| 07/27/2005 | EP1556372A2 Substituted 4-amino-1-(pyridylmethyl) piperidine as muscarinic receptor antagonists |
| 07/27/2005 | EP1556354A2 Therapeutic piperazine derivates useful for treating pain |
| 07/27/2005 | EP1556353A1 Diaryl compounds as monoamine reuptake inhibitors |
| 07/27/2005 | EP1556351A1 Secondary amino anilinic piperidines as mch1 antagonists and uses thereof |
| 07/27/2005 | EP1556347A2 Gamma lactams as prostaglandin agonists and use thereof |
| 07/27/2005 | EP1556330A2 Phenyl compounds |
| 07/27/2005 | EP1556080A1 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 07/27/2005 | EP1556066A2 Compositions and methods of use for a fibroblast growth factor |
| 07/27/2005 | EP1379523B1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 07/27/2005 | EP1377573B1 Pyrazolopyridine derivatives |
| 07/27/2005 | EP1351961B1 Substituted indolines as 5-ht receptor ligands |
| 07/27/2005 | EP1339711B1 Aminothiazoles and their use as adenosine receptor antagonists |
| 07/27/2005 | EP1315723B1 The hydrochloride salt of 5[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 07/27/2005 | EP1289559B1 Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 07/27/2005 | EP1274411B1 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 07/27/2005 | EP1272185B1 Use of quinazoline derivatives as angiogenesis inhibitors |
| 07/27/2005 | EP1263757B1 Benzthiazoles as tnf and pde-iv inhibitors |
| 07/27/2005 | CN1646695A Use of the AXL receptor for diagnosis and treatment of renal disease |
| 07/27/2005 | CN1646684A Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 07/27/2005 | CN1646531A Thioxanthine derivatives as myeloperoxidase inhibitors |
| 07/27/2005 | CN1646526A Tropane derivatives as CCR5 modulators |
| 07/27/2005 | CN1646516A Imidazolinylmethyl aralkylsulfonamides |
| 07/27/2005 | CN1646505A Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/27/2005 | CN1646504A Substituted benzoxazoles and analogues as estrogenic agents |
| 07/27/2005 | CN1646499A Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 07/27/2005 | CN1646498A Novel crystal form of 5-hydroxy-1-methylhydantoin |
| 07/27/2005 | CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators |
| 07/27/2005 | CN1646493A 5HT2C receptor modulators |
| 07/27/2005 | CN1646460A 2-(2, 6-dichlorophenyl)-diarylimidazoles |
| 07/27/2005 | CN1646160A Anti-alpha V beta 6 antibodies |